Gout is also recognized as an autoinflammatory disease, and it has been found that elevated levels of the serum cytokine IL-2 may play a key role in the pathogenesis of gout, and restoration of Th17/Treg homeostasis may be a potential therapeutic direction [45]. This evidence concerns the gene IL2 and gout.